BioRem Inc. (TSXV:BRM)

BioRem Revenue

BioRem had revenue of 11.25M CAD in the quarter ending September 30, 2025, a decrease of -24.40%. This brings the company's revenue in the last twelve months to 34.73M, down -13.85% year-over-year. In the year 2024, BioRem had annual revenue of 37.42M with 48.69% growth.

• Revenue (ttm): 34.73M
• Revenue Growth: -13.85%
• P/S Ratio: 1.23
• Revenue / Employee: 1.02M
• Employees: 34
• Market Cap: 42.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.42M	12.25M	48.69%
Dec 31, 2023	25.17M	-3.70M	-12.81%
Dec 31, 2022	28.86M	4.38M	17.91%
Dec 31, 2021	24.48M	102.65K	0.42%
Dec 31, 2020	24.38M	3.73M	18.05%
Dec 31, 2019	20.65M	-3.68M	-15.14%
Dec 31, 2018	24.33M	1.77M	7.87%
Dec 31, 2017	22.56M	6.66M	41.91%
Dec 31, 2016	15.90M	-984.03K	-5.83%
Dec 31, 2015	16.88M	6.20M	58.01%
Dec 31, 2014	10.68M	-8.91M	-45.48%
Dec 31, 2013	19.60M	4.18M	27.10%
Dec 31, 2012	15.42M	3.37M	28.00%
Dec 31, 2011	12.05M	-5.31M	-30.61%
Dec 31, 2010	17.36M	-209.88K	-1.19%
Dec 31, 2008	17.57M	8.22M	87.97%
Dec 31, 2007	9.35M	-3.11M	-24.99%
Dec 31, 2005	12.46M	-	-